# TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure

Study · id `cardio:ct-nct03296813` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03296813](<https://clinicaltrials.gov/study/NCT03296813>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03296813

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2973 participants.

## Technical summary

Registry record NCT03296813. Randomized; no masking; primary purpose treatment. Start 2018-07-11 (actual); primary completion 2022-07-29 (actual). Results posted on 2025-10-16.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 2973 participants (enrolled count; ClinicalTrials.gov record NCT03296813, source copy `cardio:ctgov-nct03296813-2025-10-16`, retrieved 2026-10-26)
- Started: 2018-07-11 (actual) (ClinicalTrials.gov record NCT03296813, source copy `cardio:ctgov-nct03296813-2025-10-16`, retrieved 2026-10-26)
- Primary completion: 2022-07-29 (actual) (ClinicalTrials.gov record NCT03296813, source copy `cardio:ctgov-nct03296813-2025-10-16`, retrieved 2026-10-26)
- Completion: 2022-07-29 (actual) (ClinicalTrials.gov record NCT03296813, source copy `cardio:ctgov-nct03296813-2025-10-16`, retrieved 2026-10-26)
- Results first posted: 2025-10-16 (ClinicalTrials.gov record NCT03296813, source copy `cardio:ctgov-nct03296813-2025-10-16`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03296813, source copy `cardio:ctgov-nct03296813-2025-10-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03296813-2025-10-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure
- Acronym: TRANSFORM-HF
- Condition: Heart Failure
- Intervention (Drug): Torsemide
- Intervention (Drug): Furosemide
- Lead sponsor: Duke University
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH
- Collaborator: Yale University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Duke University (`cardio:org-duke-university`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)
- Registry lists this organization as a collaborator: Yale University (`cardio:org-yale-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ascertaining Death Events in a Pragmatic Clinical Trial: Insights From the TRANSFORM-HF Trial (`cardio:pubmed-35181553`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial (`cardio:pubmed-36648467`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial (`cardio:pubmed-37212600`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF (`cardio:pubmed-38436075`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF (`cardio:pubmed-38745502`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparative effectiveness of torsemide vs furosemide in the management of heart failure patients: Win-ratio reanalysis of the TRANSFORM-HF trial (`cardio:pubmed-42419438`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: bce9984396e0b4a503f6de68bfaeeed197afe5a6dc18e2761c9ae60914c940f8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
